Paths of Progress
Under the direction of David Harrington, PhD, Dana-Farber biostatisticians help identify meaning and tends in cancer research.
Fall/Winter 2003
Volume 12, Number 2
Contents
Features
- The kinase race
By Richard Saltus
Finding and cataloging the abnormal enzymes — or kinases — in cancer cells, and testing existing drugs against them, may offer an "express route" to better cancer treatments. - Statistically speaking
By Robert Levy
Whether they're testing new therapies or probing gene activity, DFCI investigators can "count" on the Department of Biostatistical Science to help them design studies and interpret results. - One in a billion
By Robert Levy
New technology makes it possible to pick out a single cancer cell from a billion normal ones, and Dana-Farber researchers are at the forefront of using the process to benefit patients. - Seeking smoother waters
By Christine Cleary
Whenever it strikes a child or adult, cancer causes a ripple effect within a family. Dana-Farber's support services help its members cope during rough times. - Putting a 'nursing lens' on research
By Debra Ruder and Saul Wisnia
Dana-Farber nurse researchers are using formal investigative techniques to improve the level of care for cancer patients. - The doctor is out
By Richard Saltus
At scientific conferences worldwide, Dana-Farber physician-scientists are presenting research results and launching collaborations.
Departments
- Dateline DFCI
Recent Institute news, including an improved clinical-trials service, platelet-donation milestones, and multiple awards. - Discoveries
Researchers explore gene maps, drug resistance, kidney tumors. - First Person: Geraldine Ferraro
The former congresswoman reflects on her cancer experience and faith in the future during a conversation with Editor Debra Ruder. - A Letter from the President
Credits
President, Dana-Farber Cancer Institute Edward J. Benz Jr., MD
Chief of Staff Stephen E. Sallan, MD
Chief Medical Officer Lawrence N. Shulman, MD
Chair, Medical Oncology James D. Griffin, MD
Chair, Pediatric Oncology Stuart H. Orkin, MD
Chair, Executive Committee for Research Stanley J. Korsmeyer, MD
Senior Vice President for Experimental Medicine Lee M. Nadler, MD
Senior Vice President for Communications Steven R. Singer
Director of Publications Paul Hennessy
Editor Debra Ruder
Associate Editor Saul Wisnia
Staff Writers Christine Cleary, Robert Levy, Richard Saltus
Design John DiGianni
Production Assistance Patricia Cleary, Kristin Lacey, Caroline Woodcheke
Photography Steve Gilbert, Shawn Henry, Barry Hetherington, Bill Horsman,
Matt McKee, Mark Ostow, Laura Wulf
Paths of Progress is published twice a year by Dana-Farber Cancer Institute's Department of Communications. If you have any comments or would like to be removed from the mailing list, contact:
Debra Ruder (debra_ruder@dfci.harvard.edu)
Editor, Paths of Progress
Dana-Farber Cancer Institute, Department of Communications
375 Longwood Ave., Boston, MA 02215-5347
(617) 632-4090
Copyright © 2003 Dana-Farber Cancer Institute. All rights reserved.
